Miliotou AN - Search Results

1

Rapid on-site diagnosis of canine giardiosis: time versus performance.

Symeonidou I, Gelasakis AΙ, Miliotou AN, Angelou A, Arsenopoulos KV, Loukeri S, Papadopoulos E. Symeonidou I, et al. Among authors: miliotou an. Parasit Vectors. 2020 Nov 2;13(1):544. doi: 10.1186/s13071-020-04422-6. Parasit Vectors. 2020. PMID: 33138850 Free PMC article.

2

CAR T-cell Therapy: A New Era in Cancer Immunotherapy.

Miliotou AN, Papadopoulou LC. Miliotou AN, et al. Curr Pharm Biotechnol. 2018;19(1):5-18. doi: 10.2174/1389201019666180418095526. Curr Pharm Biotechnol. 2018. PMID: 29667553 Review.

3

Correction to: In Vitro-Transcribed (IVT)-mRNA CAR Therapy Development.

Miliotou AN, Papadopoulou LC. Miliotou AN, et al. Methods Mol Biol. 2020;2086:C1. doi: 10.1007/978-1-0716-0146-4_20. Methods Mol Biol. 2020. PMID: 31898312

4

In Vitro-Transcribed (IVT)-mRNA CAR Therapy Development.

Miliotou AN, Papadopoulou LC. Miliotou AN, et al. Methods Mol Biol. 2020;2086:87-117. doi: 10.1007/978-1-0716-0146-4_7. Methods Mol Biol. 2020. PMID: 31707670

5

PTD-mediated delivery of α-globin chain into Κ-562 erythroleukemia cells and α-thalassemic (HBH) patients' RBCs ex vivo in the frame of Protein Replacement Therapy.

Miliotou AN, Papagiannopoulou D, Vlachaki E, Samiotaki M, Laspa D, Theodoridou S, Tsiftsoglou AS, Papadopoulou LC. Miliotou AN, et al. J Biol Res (Thessalon). 2021 Jul 20;28(1):16. doi: 10.1186/s40709-021-00148-3. J Biol Res (Thessalon). 2021. PMID: 34284828 Free PMC article.

6

Development of a novel PTD-mediated IVT-mRNA delivery platform for potential protein replacement therapy of metabolic/genetic disorders.

Miliotou AN, Pappas IS, Spyroulias G, Vlachaki E, Tsiftsoglou AS, Vizirianakis IS, Papadopoulou LC. Miliotou AN, et al. Mol Ther Nucleic Acids. 2021 Sep 20;26:694-710. doi: 10.1016/j.omtn.2021.09.008. eCollection 2021 Dec 3. Mol Ther Nucleic Acids. 2021. PMID: 34703653 Free PMC article.

7

Deciphering the Role of Adrenergic Receptors in Alzheimer's Disease: Paving the Way for Innovative Therapies.

Miliotou AN, Kotsoni A, Zacharia LC. Miliotou AN, et al. Biomolecules. 2025 Jan 15;15(1):128. doi: 10.3390/biom15010128. Biomolecules. 2025. PMID: 39858522 Free PMC article. Review.

8

Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K‑562 and colorectal HCT‑116 cancer cells.

Kakafika MG, Lyta AA, Gavriilidis GI, Tsiftsoglou SA, Miliotou AN, Pappas IS, Vizirianakis IS, Papadopoulou LC, Tsiftsoglou AS. Kakafika MG, et al. Among authors: miliotou an. Int J Oncol. 2024 Apr;64(4):42. doi: 10.3892/ijo.2024.5630. Epub 2024 Mar 1. Int J Oncol. 2024. PMID: 38426621 Free PMC article.

9

Recruiting In Vitro Transcribed mRNA against Cancer Immunotherapy: A Contemporary Appraisal of the Current Landscape.

Miliotou AN, Georgiou-Siafis SK, Ntenti C, Pappas IS, Papadopoulou LC. Miliotou AN, et al. Curr Issues Mol Biol. 2023 Nov 16;45(11):9181-9214. doi: 10.3390/cimb45110576. Curr Issues Mol Biol. 2023. PMID: 37998753 Free PMC article. Review.

10

An Updated Review For Hyperuricemia and Gout Management; Special Focus on the Available Drug Delivery Systems and Clinical Trials.

Karantas ID, Miliotou AN, Siafaka PI. Karantas ID, et al. Among authors: miliotou an. Curr Med Chem. 2024;31(36):5856-5883. doi: 10.2174/0929867331666230809143758. Curr Med Chem. 2024. PMID: 37559248 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters